Company Alerts NYSE-NASDAQ November 13, 2026 Cisco Earnings: Q1 Fiscal 2027 Revenue Jumps 24% to $18.5 Billion as AI Networking Demand Lifts Outlook
Company Alerts November 13, 2026 Vanderbilt Report: SecureTech’s AI UltraProd Lands Its First U.S. Build Site, Taking Robotic 3D-Printed Housing to California
Biotechnology Pharmaceutical November 11, 2026 Hepatitis Delta Phase 3 Results: Vir’s Elebsiran and Tobevibart Meet Primary Goal in ECLIPSE 1
Health November 11, 2026 Earlier Bedtime and Weight Loss: NYU Study Links Sleep Timing, Not Sleep Length, to Pounds Lost in Prediabetes
Energy World News November 10, 2026 COP31 Antalya Opens: Climate Finance Clash, 1.5°C Overshoot Warning and What to Watch as Leaders Arrive
Breaking News Business Technology June 11, 2026 AI Infrastructure in 2026: Why Today’s Biggest Technology Race Is About Chips, Power, and Water
Breaking News US News June 11, 2026 US Strikes on Iran Escalate for a Second Day as Strait of Hormuz Dispute Rattles Oil Markets
Breaking News Finance Technology June 11, 2026 Technology News Today: AI, Big IPOs and the Future Arriving Fast
Blockchain News Breaking News Business Cryptocurrency Finance June 10, 2026 Crypto News This Week: Saylor Sells Bitcoin, ETF Outflows Mount, and the SEC Plots a Reset
Breaking News Business Company Alerts NYSE-NASDAQ May 26, 2026 AI Infrastructure Stocks to Watch: Why Z Squared Stands Out
AI & Machine Learning Breaking News May 7, 2026 Anthropic’s $1.5B Venture Exposes the Real Enterprise AI Bottleneck: It’s Not the Technology
Breaking News Top Stories April 14, 2026 When Markets Price Relief Before Resolution: What the Iran Ceasefire Tells Us About Geopolitical Risk
Company Alerts NYSE-NASDAQ November 13, 2026 Cisco Earnings: Q1 Fiscal 2027 Revenue Jumps 24% to $18.5 Billion as AI Networking Demand Lifts Outlook
Company Alerts November 13, 2026 Vanderbilt Report: SecureTech’s AI UltraProd Lands Its First U.S. Build Site, Taking Robotic 3D-Printed Housing to California
Biotechnology Pharmaceutical November 11, 2026 Hepatitis Delta Phase 3 Results: Vir’s Elebsiran and Tobevibart Meet Primary Goal in ECLIPSE 1
Health November 11, 2026 Earlier Bedtime and Weight Loss: NYU Study Links Sleep Timing, Not Sleep Length, to Pounds Lost in Prediabetes
